Skin Toxicity Prevention Protocol with Panitumumab treatment for Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
Interventions: A group Panitumumab is administered intravenously in 6mg/kg by biweekly skin care+antibiotics Clarithromycin is administered orally twice a day B group Panitumumab is administered intravenously in 6mg/kg by biweekly skin care only Primary outcome(s): incidence rates of skin toxicity (>=Grade2) with or without antibiotics during the 6 weeks from the treatment started Study Design: Parallel Randomized
创建时间：
2013-10-15
